Reduction of osteosarcoma cell proliferation, apoptosis induction, suppression of cell motility, and chemotherapy drug sensitivity enhancement as an effect of knocking out of mutant TP53 was reported [10,11,12]. Here, TP53 is linked to osteosarcoma.